|
October 3 in History
Events and happenings on 3 October in History
3 October 2001
3 October 2002
Highlights: State cabinet disucsses on weiver of interest to agricultural loans in drought-hit areas
3 October 2003
Highlights: CM speaks for the first time after Naxal attack
3 October 2004
3 October 2005
3 October 2006
Highlights: APSRTC Union serves strike notice
3 October 2007
Highlights: AP High Court to hear petition against land allotment
|
His Excellency, Dr A P J Abdul Kalam, President of India, inaugurates Indian Immunologicals’ Human Vaccine Plant
Indian Immunologicals’ aims at being a global player in vaccine business
|
Hyderabad, 3 October, 2003
His Excellency Dr A P J Abdul Kalam, President of India, today inaugurated the state of the art, Human Vaccines Plant and R & D Centre set up by Indian Immunologicals Limited (IIL), a wholly owned subsidiary of the National Dairy Development Board (NDDB). His Excellency the Honorable Governor of Andhra Pradesh Shri Surjit Singh Barnala and Shri K. Vijayarama Rao, Minister for Commercial Taxes, Govt. of AP also graced the occasion.
These facilities have been set up with an investment of Rs 50 crores. The plant has been designed to manufacture various human vaccines such as Recombinant Hepatitis B, Measles, Diphtheria, Pertussis and Tetanus. In addition, the plant has the capability and technology to produce new combination vaccines. This unique complex houses several plants, which can simultaneously manufacture 200 million doses of each vaccine per annum.
Speaking on the occasion Dr. Amrita Patel, Chairman, NDDB said "This plant marks a major milestone in indigenous technology development and places India on the global map in modern vaccine technology. We are committed to producing world class vaccines and make it available at affordable prices"
Apart from catering to the national needs, the vaccines produced in this plant will also be exported to meet the growing demand for quality vaccines under UNICEF’s vaccine procurement programme. Indian Immunologicals’ already exports its veterinary vaccines to a number of countries and is the largest supplier of FMD vaccines to Food & Agriculture Organisation. The global market for human & animal vaccines is about US$ 8 billion and is growing at 9% p.a. Indian Immunologicals, targets to be a major vaccine player in both animal and humane vaccines and plans to garner a significant share of the global market.
Apart from the manufacturing unit, H.E. The President also inaugurated the Research & Development Center. Set up with an investment of Rs 8 crores this R & D Center will develop various animal and human vaccines and biologicals. "Indian Immunologicals will undertake research which will lead to production of not only low cost but also thermostable products, which do not require a cold chain. In persuance of this a DNA rabies vaccine is being developed in collaboration with the Indian Institute of Science, which is in advance stage of trials" Dr. Patel added. The research centre will focus not only on developing vaccines based on modern biotechnology, but will also work towards developing therapeutics and diagnostic agents based on molecular biology. An important area of IIL’s research will be in the area of Hybridoma and Human monoclonal antibodies for therapeutic purposes. The R &D center is designed to emerge as a Centre of Excellence in modern biotechnology.
IIL does not restrict itself to merely being a vaccine manufacturer but is also a successful
vaccination service provider through its chain of 1600 Abhay Clinics and 500 Pratirodh Centers.
| |
About Indian Immunologicals Limited
|
Indian Immunologicals Limited (IIL), is a wholly owned subsidiary of the National Dairy
Development Board (NDDB) and was established in 1983. The facility was set up to manufacture Foot & Mouth disease (FMD) vaccine with technical know-how obtained from The Wellcome Foundation, UK. Subsequently, IIL has developed and introduced several veterinary biologicals through its own R&D efforts.
Today, IIL is the market leader in veterinary biologicals in India and operates the world’s largest plant for veterinary vaccines. IIL’s manufacturing facilities, for, both animal and human, are WHO-GMP and ISO-9002 certified. IIL is also India’s largest veterinary products exporter. Exports of animal health products contributed to 30% of its total turnover of Rs. 55 crores in 2002 - 03.
IIL is not only a vaccine manufacturer, but also a vaccination service provider through its ‘Pratirodh Centers’ catering to immunization needs of the farmer and Abhay Clinics catering to the vaccination needs of human beings. IIL’s mission is to make immunity affordable to the people of India in both the animal health and human health sectors.
|
|
Clickz..
Asuku.com
Talk about Everything and Anything...
AndhraNews.com
The Andhra Pradesh Discussion Forum
ElectionsInfo.com
Coverage on Elections round the World
|
